Edition:
India

John Johnson Agrees To Become Permanent CEO Of Melinta Therapeutics


Wednesday, 19 Dec 2018 

Dec 19 (Reuters) - Melinta Therapeutics Inc ::JOHN H. JOHNSON AGREES TO BECOME PERMANENT CHIEF EXECUTIVE OFFICER OF MELINTA THERAPEUTICS.MELINTA THERAPEUTICS INC - JOHNSON SERVED AS INTERIM CEO OF COMPANY SINCE OCTOBER 22, 2018.MELINTA THERAPEUTICS - JOHNSON TO BECOME CEO SUBJECT TO TERMS OF AN EMPLOYMENT CONTRACT, CLOSE OF COMMITMENT FOR UP TO $135 MILLION CREDIT FACILITY. 

Company Quote

4.33
0.06 +1.41%
18 Apr 2019